April 4, 2024 — Siemens Healthineers announces the Food and Drug Administration 510(k) clearance of the MAMMOMAT B.brilliant — the first completely redesigned mammography platform in more than 10 years. The clearance includes elements involving full-field digital mammography, breast biopsy, and titanium contrast-enhanced mammography. The system’s new features enhance user ergonomics and workflow, as well as reduce patient discomfort. The company recently filed a Premarket Approval application for the three-dimensional portion of the MAMMOMAT B.brilliant, featuring new tomosynthesis acquisition and reconstruction technology.
Siemens Healthineers Unveils Next-Generation Mammography Platform, Germany
Date:
Updated: [falahcoin_post_modified_date]
More like thisRelated
Revolutionary Small Business Exchange Network Connects Sellers and Buyers
Revolutionary SBEN connects small business sellers and buyers, transforming the way businesses are bought and sold in the U.S.
District 1 Commissioner Race Results Delayed by Recounts & Ballot Reviews, US
District 1 Commissioner Race in Orange County faces delays with recounts and ballot reviews. Find out who will come out on top in this close election.
Fed Minutes Hint at Potential Rate Cut in September amid Economic Uncertainty, US
Federal Reserve minutes suggest potential rate cut in September amid economic uncertainty. Find out more about the upcoming policy decisions.
Baltimore Orioles Host First-Ever ‘Faith Night’ with Players Sharing Testimonies, US
Experience the powerful testimonies of Baltimore Orioles players on their first-ever 'Faith Night.' Hear how their faith impacts their lives on and off the field.
